Actively Recruiting
Evaluation of Electrocardiographic Measurements by High Density Electrode ECG for Ventricular Arrhythmias
Led by University Hospital, Bordeaux · Updated on 2024-12-24
1800
Participants Needed
11
Research Sites
312 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to improve the detection of cardiac electrical activity by comparing a new high-density ECG method with the conventional 12-lead ECG. The study focuses on patients with ventricular arrhythmias or related heart conditions and explores whether using 128 body surface electrodes can provide more detailed information about heart activity than the standard 12 leads. This could help identify electrical patterns associated with severe ventricular arrhythmias or impaired ventricular conduction. Participants will undergo two types of ECG recordings performed at the same time: the experimental high-density ECG using 128 electrodes placed on the body surface and the standard 12-lead ECG using a subset of these electrodes plus limb electrodes. The high-density ECG involves applying strips of electrodes with adhesive tape and conductive gel, with recordings lasting between 10 to 30 minutes. This simultaneous recording allows comparison of electrical signals captured by both methods. During the study visit, researchers will measure various electrical criteria from the high-density ECG, including amplitude, cardiac timing, duration, and anatomical locations of heart signals. These measurements aim to provide more detailed cardiac information for patients. Participants may be monitored for safety and undergo assessments relevant to their heart condition. The total participation time covers the ECG procedure and associated evaluations on the study day.
CONDITIONS
Official Title
Evaluation of Electrocardiographic Measurements by High Density Electrode ECG
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient managed at the Bordeaux University Hospital for assessment of documented severe ventricular arrhythmia (VF, sudden resuscitated death) or suspected (syncope, family history of sudden death, ECG or Holter abnormality) or impaired ventricular conduction
- Patients managed for prophylactic ventricular defibrillator implantation, according to international recommendations: Heart disease with ejection fraction < 35%, heart disease with sustained ventricular tachycardia, cardiomyopathies with high rhythmic risk
- Women of childbearing age with effective contraception
You will not qualify if you...
- Patients under 14 years old
- Pregnant or nursing woman
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 11 locations
1
CHU Clermont-Ferrand
Clermont-Ferrand, France, 63000
Not Yet Recruiting
2
Hôpital Privé Jacques Cartier
Massy, France, 91300
Not Yet Recruiting
3
Hôpital Pitié-Salpêtrière
Paris, France, 75013
Not Yet Recruiting
4
Hôpital Bichat
Paris, France, 75018
Not Yet Recruiting
5
Hôpital européen Georges Pompidou
Paris, France, 75908
Not Yet Recruiting
6
Bordeaux University Hospital
Pessac, France, 33604
Actively Recruiting
7
CHR Pontchaillou
Rennes, France, 35033
Not Yet Recruiting
8
CHU de Saint-Etienne
Saint-Etienne, France, 42055
Not Yet Recruiting
9
CHU de Toulouse
Toulouse, France, 35033
Not Yet Recruiting
10
CHU de Nancy
Vandœuvre-lès-Nancy, France, 54511
Not Yet Recruiting
11
Centre Hospitalier Princesse Grace
Monaco, Monaco, 98000
Not Yet Recruiting
Research Team
M
Michel HAÏSSAGUERRE, MD-PhD
A
Aude CATHALA
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here